Skip to main content
. 2023 Feb 22;23:105. doi: 10.1186/s12879-023-08057-7

Table 2.

Severity and prevalence of symptoms at D28+ survey (N = 411)

Symptom Mild Moderate Severe Overall prevalence*
Cough 20.4% 7.8% 1.2% 29.4%
Headache 17.3% 9.0% 1.7% 28.0%
Myalgia 15.3% 8.8% 1.9% 26.0%
Anosmia 20.2% NA 3.4% 23.6%
Dyspnea 14.6% 7.8% 0.7% 23.1%
Post-exertion polypnea 12.7% 7.4% 1.0% 21.1%
Ageusia 18.0% NA 2.2% 20.2%
Cognitive disturbances 11.2% 6.6% 1.7% 19.5%
Chest pain/tightness 12.4% 4.4% 0.7% 17.5%
Arthralgia 7.1% 6.1% 2.0% 15.1%
Hair loss 6.6% 5.1% 2.4% 14.1%
Palpitations 6.3% 5.1% 0.7% 12.2%
Nausea 6.1% 3.2% 2.2% 11.4%
Diaphoresis 4.6% 3.4% 2.7% 10.7%
Rhinorrhea 8.0% 2.2% 0.2% 10.5%
Pharyngitis 7.5% 1.5% 0.5% 9.5%
Ear pain 6.6% 2.2% 0.7% 9.5%
Diarrhea 3.7% 2.2% 2.4% 8.3%
Rash 3.9% 2.0% 0.5% 6.3%
Chills/shivering 4.6% 1.2% 0.2% 6.1%
Need for oxygen 2.4% 2.4% 1.0% 5.9%
Loss of hearing 4.0% NA 0.0% 4.0%
Fever 2.4% 0.2% 0.5% 3.2%
Vomiting 1.9% 0.0% 0.5% 2.4%
Thromboembolism 0.5% 1.0% 0.2% 1.7%
CKD 0.7% 0.2% 0.2% 1.2%

For diarrhea and vomiting, 1–2 was classified as mild, 3–4 as moderate, and 5 or more as severe. For loss of hearing, smell, and taste, “same as usual” was considered none, “less than usual” was considered mild, and “no sense” was considered severe

CKD chronic kidney disease, NA not applicable

*Overall prevalence represents the sum of mild, moderate, and severe categories